CNR2 inverse-agonist AM630 increases citrate synthase activity in the skeletal muscle of diet induced obese rats
Obesity Research & Clinical Practice · 2026-09
DOI: 10.1016/j.orcp.2026.09.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity Research & Clinical Practice, 2026-09. Verfasst von Lannie O'Keefe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Health and Sport, Victoria University, PO Box 14428, Melbourne, VIC, 8001, Australia. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Rotary Health, Allen Foundation Inc.
Abstract (Originalsprache)
AIMS: Diet-induced obesity (DIO) results in alterations in skeletal muscle metabolism that affects oxidative capacity and adiponectin signaling. In obesity, agonism of the cannabinoid receptor 2 (CNR2) has been shown to reduce body weight and increase energy expenditure but the effect on skeletal muscle metabolism is unknown. We aimed to investigate the effects of a CNR2 inverse agonist, AM630 and a CNR2 agonist, AM1241, on skeletal muscle. METHODS: Male Sprague Dawley rats (n = 30) were fed a high fat diet (HFD) (21% fat) for 9 weeks, then received daily intraperitoneal injections with vehicle (n = 10), AM630 (0.3 mg/kg, n = 10) or AM1241 (3 mg/kg, n = 10) for another six weeks. Skeletal muscle, citrate synthase (CS) activity, mRNA and protein expression of markers of the fatty acid oxidative pathways with and without acute ex vivo adiponectin (0.1 mg/ml) treatment were measured. RESULTS: AM630 increased CS enzyme activity in the red gastrocnemius. In addition, in soleus AM630 increased the ratio of 4EBP1 phosphorylated to total protein, reduced AMPKα phosphorylated to total protein and reduced PDK4 mRNA. In soleus, AM1241 activated 4EBP1 and reduced PDK4 mRNA. While, in the EDL both AM630 and AM1241 reduced PGCl-α and AM1241 increased AdipoR1 mRNA. Interestingly, in the EDL, acute ex vivo adiponectin exposure reduced 4EBP1 phosphorylated to total protein in control animals, however increased PGCl-α in AM630 treated animals. CONCLUSIONS: Targeting CNR2 in obesity alters mitochondrial content in the skeletal muscle of rodents, yet the relationship appears to be complex and further exploration is required.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Health and Sport, Victoria University, PO Box 14428, Melbourne, VIC, 8001, Australia.
- Institute for Health and Sport, Victoria University, PO Box 14428, Melbourne, VIC, 8001, Australia; School of Science, Western Sydney University, Campbelltown, NSW, 2560, Australia.
- Institute for Health and Sport, Victoria University, PO Box 14428, Melbourne, VIC, 8001, Australia; Department of Sport Physiology, Faculty of Sport Science, Razi University, Kermanshah, Iran.
- Institute for Health and Sport, Victoria University, PO Box 14428, Melbourne, VIC, 8001, Australia; The Florey Institute of Neuroscience and Mental Health, Parkville, Melbourne, VIC, 3052, Australia.
- School of Environment and Sciences, Griffith University, Nathan, QLD, 4111, Australia; School of Health, University of the Sunshine Coast, Sippy Downs, QLD, 4556, Australia.
- Institute for Health and Sport, Victoria University, PO Box 14428, Melbourne, VIC, 8001, Australia; Australian Institute for Musculoskeletal Science (AIMSS), Victoria University, Melbourne, VIC, 8001, Australia. Electro…
Förderung
- Australian Rotary Health
- Allen Foundation Inc
Zitieren
APA
O'Keefe, L., Simcocks, A. C., Jenkin, K. A., Monazzami, A., Chandrasiri, S., Mathai, M. L., Hryciw, D. H., & McAinch, A. J. (2026). CNR2 inverse-agonist AM630 increases citrate synthase activity in the skeletal muscle of diet induced obese rats. Obesity Research & Clinical Practice. https://doi.org/10.1016/j.orcp.2026.09.005
Vancouver
O'Keefe L, Simcocks AC, Jenkin KA, Monazzami A, Chandrasiri S, Mathai ML, et al. CNR2 inverse-agonist AM630 increases citrate synthase activity in the skeletal muscle of diet induced obese rats. Obesity Research & Clinical Practice. 2026. doi:10.1016/j.orcp.2026.09.005
BibTeX
@article{OKeefe2026,
author = {O'Keefe, Lannie and Simcocks, Anna C and Jenkin, Kayte A and Monazzami, Amirabbas and Chandrasiri, Shavin and Mathai, Michael L and Hryciw, Deanne H and McAinch, Andrew J},
title = {CNR2 inverse-agonist AM630 increases citrate synthase activity in the skeletal muscle of diet induced obese rats},
journal = {Obesity Research & Clinical Practice},
year = {2026},
doi = {10.1016/j.orcp.2026.09.005}
}
EUVIMED